78 related articles for article (PubMed ID: 9637818)
1. [Development of the intratracheal infection model of experimental murine mycobacteriosis: comparison with the intravenous infection model].
Doi N
Kekkaku; 1998 May; 73(5):339-47. PubMed ID: 9637818
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of the quantitative intratracheal infection model of experimental murine mycobacteriosis].
Doi N
Kekkaku; 1999 Feb; 74(2):121-4. PubMed ID: 10191605
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model].
Doi N
Kekkaku; 1998 Feb; 73(2):53-64. PubMed ID: 9545697
[TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
7. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
8. Development of a Mycobacterium bovis intranasal challenge model in mice.
Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
[TBL] [Abstract][Full Text] [Related]
9. Specific bacterial genotypes of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model.
Hernandez Pando R; Aguilar D; Cohen I; Guerrero M; Ribon W; Acosta P; Orozco H; Marquina B; Salinas C; Rembao D; Espitia C
Tuberculosis (Edinb); 2010 Jul; 90(4):268-77. PubMed ID: 20580613
[TBL] [Abstract][Full Text] [Related]
10. Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease.
Medina E; Ryan L; LaCourse R; North RJ
Tuberculosis (Edinb); 2006 Jan; 86(1):20-7. PubMed ID: 16253563
[TBL] [Abstract][Full Text] [Related]
11. Oral infection of ferrets with virulent Mycobacterium bovis or Mycobacterium avium: susceptibility, pathogenesis and immune response.
Cross ML; Labes RE; Mackintosh CG
J Comp Pathol; 2000 Jul; 123(1):15-21. PubMed ID: 10906251
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice.
Radaeva TV; Nikonenko BV; Mischenko VV; Averbakh MM; Apt AS
Tuberculosis (Edinb); 2005; 85(1-2):65-72. PubMed ID: 15687029
[TBL] [Abstract][Full Text] [Related]
13. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency of anti-inflammatory therapy for experimental tuberculosis in genetically tuberculosis-sensitive mice].
Kondrat'eva TK; Rubakova EI; Evstifeev VV; Sosunov VV; Petrovskaia SN; Kondrat'eva AV; Apt AS
Probl Tuberk Bolezn Legk; 2006; (10):63-5. PubMed ID: 17139836
[TBL] [Abstract][Full Text] [Related]
15. Specificity and efficacy of dendritic cell-based vaccination against tuberculosis with complex mycobacterial antigens in a mouse model.
Rubakova E; Petrovskaya S; Pichugin A; Khlebnikov V; McMurray D; Kondratieva E; Baturina I; Kondratieva T; Apt A
Tuberculosis (Edinb); 2007 Mar; 87(2):134-44. PubMed ID: 17011827
[TBL] [Abstract][Full Text] [Related]
16. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice.
Dutta NK; Mazumdar K; Dastidar SG; Park JH
Int J Antimicrob Agents; 2007 Oct; 30(4):336-40. PubMed ID: 17644321
[TBL] [Abstract][Full Text] [Related]
17. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
[TBL] [Abstract][Full Text] [Related]
18. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
19. Real-time fluorescence monitoring of phenothiazinium photosensitizers and their anti-mycobacterial photodynamic activity against Mycobacterium bovis BCG in in vitro and in vivo models of localized infection.
O'Riordan K; Akilov OE; Chang SK; Foley JW; Hasan T
Photochem Photobiol Sci; 2007 Oct; 6(10):1117-23. PubMed ID: 17914486
[TBL] [Abstract][Full Text] [Related]
20. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model.
Radaeva TV; Kondratieva EV; Sosunov VV; Majorov KB; Apt A
Tuberculosis (Edinb); 2008 Nov; 88(6):576-85. PubMed ID: 18667358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
